MicroTech Medical Hangzhou Co Ltd
HKEX:2235
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
Price:
7.49
HKD
0.81%
Market Closed
Market Cap:
HK$3.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MicroTech Medical Hangzhou Co Ltd
HKEX:2235
|
CN |
Income Statement
Earnings Waterfall
MicroTech Medical Hangzhou Co Ltd
MicroTech Medical Hangzhou Co Ltd
Income Statement
MicroTech Medical Hangzhou Co Ltd
MicroTech Medical Hangzhou Co Ltd
Currency: CNY
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Revenue |
174
N/A
|
213
+22%
|
253
+19%
|
293
+16%
|
346
+18%
|
441
+28%
|
661
+50%
|
|
| Gross Profit | ||||||||
| Cost of Revenue |
(95)
|
(108)
|
(132)
|
(146)
|
(170)
|
(226)
|
(308)
|
|
| Gross Profit |
79
N/A
|
105
+33%
|
121
+15%
|
147
+22%
|
175
+19%
|
214
+22%
|
353
+64%
|
|
| Operating Income | ||||||||
| Operating Expenses |
(200)
|
(196)
|
(313)
|
(346)
|
(307)
|
(294)
|
(335)
|
|
| Selling, General & Administrative |
(157)
|
(197)
|
(252)
|
(289)
|
(246)
|
(240)
|
(273)
|
|
| Research & Development |
(58)
|
(69)
|
(67)
|
(73)
|
(74)
|
(75)
|
(76)
|
|
| Depreciation & Amortization |
(7)
|
0
|
(8)
|
0
|
(8)
|
0
|
0
|
|
| Other Operating Expenses |
22
|
70
|
14
|
16
|
20
|
21
|
14
|
|
| Operating Income |
(120)
N/A
|
(91)
+24%
|
(192)
-110%
|
(198)
-3%
|
(132)
+33%
|
(80)
+39%
|
18
N/A
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
85
|
50
|
75
|
61
|
73
|
61
|
35
|
|
| Non-Reccuring Items |
(0)
|
(4)
|
(4)
|
(2)
|
(4)
|
(8)
|
(9)
|
|
| Total Other Income |
(0)
|
(0)
|
(5)
|
(5)
|
(1)
|
(1)
|
(4)
|
|
| Pre-Tax Income |
(35)
N/A
|
(46)
-31%
|
(125)
-173%
|
(144)
-15%
|
(63)
+56%
|
(28)
+56%
|
40
N/A
|
|
| Net Income | ||||||||
| Tax Provision |
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(35)
|
(46)
|
(125)
|
(144)
|
(63)
|
(28)
|
40
|
|
| Net Income (Common) |
(35)
N/A
|
(46)
-31%
|
(125)
-173%
|
(144)
-15%
|
(63)
+56%
|
(28)
+56%
|
40
N/A
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.1
-25%
|
-0.29
-190%
|
-0.34
-17%
|
-0.15
+56%
|
-0.07
+53%
|
0.1
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
